中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2013年
13期
181-182
,共2页
郑乃莹%邵汛帆%莫志文%黄中
鄭迺瑩%邵汛帆%莫誌文%黃中
정내형%소신범%막지문%황중
调强放射治疗%鼻咽癌%临床效果%术后预后
調彊放射治療%鼻嚥癌%臨床效果%術後預後
조강방사치료%비인암%림상효과%술후예후
Intensity modulated radiation therapy%Nasopharyngeal carcinoma%Clinical effect%Postoperative prognostic
目的探讨早期鼻咽癌患者调强放疗的预后因素。方法回顾性分析了我院放疗科共169例鼻咽癌患者的临床资料并对其进行了分析。将放射治疗应用到临床诊断治疗当中,旨在探讨该方法的实际应用效果,为临床研究和应用提供参考。结果本研究169例患者中鼻咽癌经单纯放射治疗后4的生存率为85.7%,影响患者鼻咽癌放射治疗生存率的预后因素主要包括:T分期、是否淋巴结转移,而预后与化疗与否似乎未见明显相关。结论提示对于早期的鼻咽癌患者,预后相关因素为T分期、是否淋巴结转移,而预后与化疗与否似乎未见明显相关。
目的探討早期鼻嚥癌患者調彊放療的預後因素。方法迴顧性分析瞭我院放療科共169例鼻嚥癌患者的臨床資料併對其進行瞭分析。將放射治療應用到臨床診斷治療噹中,旨在探討該方法的實際應用效果,為臨床研究和應用提供參攷。結果本研究169例患者中鼻嚥癌經單純放射治療後4的生存率為85.7%,影響患者鼻嚥癌放射治療生存率的預後因素主要包括:T分期、是否淋巴結轉移,而預後與化療與否似乎未見明顯相關。結論提示對于早期的鼻嚥癌患者,預後相關因素為T分期、是否淋巴結轉移,而預後與化療與否似乎未見明顯相關。
목적탐토조기비인암환자조강방료적예후인소。방법회고성분석료아원방료과공169례비인암환자적림상자료병대기진행료분석。장방사치료응용도림상진단치료당중,지재탐토해방법적실제응용효과,위림상연구화응용제공삼고。결과본연구169례환자중비인암경단순방사치료후4적생존솔위85.7%,영향환자비인암방사치료생존솔적예후인소주요포괄:T분기、시부림파결전이,이예후여화료여부사호미견명현상관。결론제시대우조기적비인암환자,예후상관인소위T분기、시부림파결전이,이예후여화료여부사호미견명현상관。
Objective To explore the prognostic factors of early nasopharyngeal carcinoma patients with intensity modulated radiation therapy. Methods The clinical data of 169 patients with nasopharyngeal carcinoma in our hospital of radiotherapy department were analyzed retrospectively. This article applied radiation therapy into clinical diagnosis and treatment for exploring the practical application effect of this method and providing a reference for clinical study. Results In this study, the four-year survival rate of 169 cases with nasopharyngeal carcinoma after radiotherapy alone in them was 85.7%. The factors influencing the prognosis on survival rate of patients with nasopharyngeal carcinoma radiotherapy mainly included T-staging, lymph node metastasis or not, and there was no obvious correlation between prognosis and chemotherapy or not. Conclusion It suggested that the prognosis factors of patients with early nasopharyngeal carcinoma are T-staging and lymph node metastasis or not and there is no obvious correlation between prognosis and chemotherapy or not.